T. Rowe Price reports 8.1% Ameren stake
T. Rowe Price Associates, Inc. reported beneficial ownership of 21,790,077 shares of Ameren Corporation common stock, representing 8.1% of the class as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. reported beneficial ownership of 21,790,077 shares of Ameren Corporation common stock, representing 8.1% of the class as of 12/31/2025.
The firm has sole voting power over 21,085,162 shares and sole dispositive power over 21,789,822 shares, with no shared voting or dispositive power. The position is held in the ordinary course of business and is not for the purpose of changing or influencing control of Ameren. T. Rowe Price Associates also states that filing this report is not an admission of beneficial ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Ameren (AEE) does T. Rowe Price Associates hold?
What dispositive power does T. Rowe Price Associates report over Ameren (AEE) stock?
Is T. Rowe Price Associates seeking to influence control of Ameren (AEE)?
What type of SEC filing did Ameren (AEE) trigger with T. Rowe Price Associates’ stake?
AI-generated analysis. How Rhea-AI works. Not financial advice.